BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Covington
Queensland Health
Colorcon
Farmers Insurance
Novartis
Chubb
Deloitte
Express Scripts

Generated: January 24, 2018

DrugPatentWatch Database Preview

FLUOXETINE HYDROCHLORIDE; OLANZAPINE - Generic Drug Details

« Back to Dashboard

What are the generic sources for fluoxetine hydrochloride; olanzapine and what is the scope of fluoxetine hydrochloride; olanzapine freedom to operate?

Fluoxetine hydrochloride; olanzapine
is the generic ingredient in two branded drugs marketed by Par Pharm, Sandoz, Teva Pharms, and Lilly, and is included in five NDAs. There are two patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Fluoxetine hydrochloride; olanzapine has forty-seven patent family members in twenty-five countries.

There are twenty-seven drug master file entries for fluoxetine hydrochloride; olanzapine. Five suppliers are listed for this compound.
Summary for FLUOXETINE HYDROCHLORIDE; OLANZAPINE
International Patents:47
US Patents:2
Tradenames:2
Applicants:4
NDAs:5
Drug Master File Entries: 27
Suppliers / Packagers: 5
Clinical Trials: 593
Drug Prices:see low prices
DailyMed Link:FLUOXETINE HYDROCHLORIDE; OLANZAPINE at DailyMed
Pharmacology for FLUOXETINE HYDROCHLORIDE; OLANZAPINE

US Patents and Regulatory Information for FLUOXETINE HYDROCHLORIDE; OLANZAPINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-004 Dec 24, 2003 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-002 Dec 24, 2003 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 202074-001 Mar 25, 2013 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-001 Apr 9, 2007 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-005 Dec 24, 2003 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-004 Dec 24, 2003 AB RX Yes No ➤ Subscribe ➤ Subscribe Y Y Y ➤ Subscribe
Lilly SYMBYAX fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 021520-003 Dec 24, 2003 AB RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 077742-003 Nov 2, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 078901-004 Nov 16, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms OLANZAPINE AND FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride; olanzapine CAPSULE;ORAL 077528-003 Jun 19, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for FLUOXETINE HYDROCHLORIDE; OLANZAPINE

International Patents for FLUOXETINE HYDROCHLORIDE; OLANZAPINE

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
AstraZeneca
Teva
Moodys
Federal Trade Commission
Cantor Fitzgerald
UBS
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot